2024 Q3 Form 10-K Financial Statement

#000095017024100587 Filed on August 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024
Revenue $118.8M $114.4M $430.5M
YoY Change 16.96% 20.88% 22.7%
Cost Of Revenue $31.93M $30.74M $123.7M
YoY Change 1.14% -0.37% 10.94%
Gross Profit $86.87M $83.64M $306.9M
YoY Change 24.1% 31.16% 28.17%
Gross Profit Margin 73.12% 73.13% 71.28%
Selling, General & Admin $61.70M $52.02M $225.4M
YoY Change 11.23% 2.58% 5.72%
% of Gross Profit 71.02% 62.19% 73.46%
Research & Development $32.43M $29.84M $113.6M
YoY Change 13.79% 17.02% 21.08%
% of Gross Profit 37.33% 35.68% 37.03%
Depreciation & Amortization $4.467M $4.698M $16.70M
YoY Change 11.42% 20.06% 9.04%
% of Gross Profit 5.14% 5.62% 5.44%
Operating Expenses $94.13M $83.34M $339.1M
YoY Change 12.1% 9.35% 9.84%
Operating Profit -$7.254M $302.0K -$32.19M
YoY Change -48.06% -102.43% -53.52%
Interest Expense $3.422M $413.0K $2.285M
YoY Change 8674.36% -1158.97% 1364.74%
% of Operating Profit 136.75%
Other Income/Expense, Net $3.422M $2.285M
YoY Change -478.54% -554.27%
Pretax Income -$3.832M $715.0K -$29.91M
YoY Change -74.3% -105.83% -57.23%
Income Tax $688.0K $1.312M $2.115M
% Of Pretax Income 183.5%
Net Earnings -$4.520M -$597.0K -$32.02M
YoY Change -70.5% -94.8% -53.88%
Net Earnings / Revenue -3.8% -0.52% -7.44%
Basic Earnings Per Share -$0.06 -$0.45
Diluted Earnings Per Share -$0.06 -$0.01 -$0.45
COMMON SHARES
Basic Shares Outstanding 74.70M 73.43M 71.49M
Diluted Shares Outstanding 75.60M 71.49M

Balance Sheet

Concept 2024 Q3 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $253.8M $208.4M $208.4M
YoY Change 79.4% 59.82% 59.82%
Cash & Equivalents $253.8M $208.4M $208.4M
Short-Term Investments
Other Short-Term Assets $25.17M $23.14M $23.14M
YoY Change 18.18% 15.98% 15.98%
Inventory
Prepaid Expenses $11.29M $9.031M
Receivables $74.83M $95.10M $108.4M
Other Receivables $2.732M $2.743M $2.743M
Total Short-Term Assets $356.6M $342.7M $342.7M
YoY Change 44.52% 34.46% 34.46%
LONG-TERM ASSETS
Property, Plant & Equipment $39.47M $18.94M $40.33M
YoY Change 123.06% 15.75% 20.21%
Goodwill $286.5M $286.0M
YoY Change 2.83% 2.54%
Intangibles $37.29M $40.29M
YoY Change -8.04% -6.85%
Long-Term Investments
YoY Change
Other Assets $22.61M $5.262M $23.76M
YoY Change 1143.51% 185.05% 29.29%
Total Long-Term Assets $385.8M $390.3M $390.3M
YoY Change 4.04% 4.35% 4.35%
TOTAL ASSETS
Total Short-Term Assets $356.6M $342.7M $342.7M
Total Long-Term Assets $385.8M $390.3M $390.3M
Total Assets $742.4M $733.0M $733.0M
YoY Change 20.21% 16.55% 16.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.01M $13.35M $13.35M
YoY Change 158.9% 121.8% 121.8%
Accrued Expenses $42.56M $12.04M $60.11M
YoY Change 218.33% 3.56% 16.97%
Deferred Revenue $203.1M $218.9M
YoY Change 6.1% 14.59%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $273.3M $300.6M $300.6M
YoY Change 11.95% 15.92% 15.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $25.74M $4.610M $27.78M
YoY Change 176.08% -50.84% 3.16%
Total Long-Term Liabilities $25.74M $4.610M $27.78M
YoY Change 176.08% -50.84% 3.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $273.3M $300.6M $300.6M
Total Long-Term Liabilities $25.74M $4.610M $27.78M
Total Liabilities $300.3M $329.8M $329.8M
YoY Change 10.85% 14.62% 14.62%
SHAREHOLDERS EQUITY
Retained Earnings -$491.7M -$487.2M
YoY Change 4.51% 7.04%
Common Stock $78.00K $75.00K
YoY Change 13.04% 8.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $442.1M $403.2M $403.2M
YoY Change
Total Liabilities & Shareholders Equity $742.4M $733.0M $733.0M
YoY Change 20.21% 16.55% 16.55%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024
OPERATING ACTIVITIES
Net Income -$4.520M -$597.0K -$32.02M
YoY Change -70.5% -94.8% -53.88%
Depreciation, Depletion And Amortization $4.467M $4.698M $16.70M
YoY Change 11.42% 20.06% 9.04%
Cash From Operating Activities $24.45M $27.08M $67.23M
YoY Change 110.52% 154.19% 144.59%
INVESTING ACTIVITIES
Capital Expenditures $1.888M $1.910M $2.457M
YoY Change 65.47% 5.76% 11.08%
Acquisitions $897.0K $10.97M
YoY Change 66.16%
Other Investing Activities -$897.0K -$10.97M -$10.97M
YoY Change 79.77% 66.16%
Cash From Investing Activities -$2.785M -$12.88M -$19.83M
YoY Change -7.23% 62.87% 38.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.53M 6.745M 30.33M
YoY Change 1173.27% -90.94% -52.69%
NET CHANGE
Cash From Operating Activities 24.45M 27.08M 67.23M
Cash From Investing Activities -2.785M -12.88M -19.83M
Cash From Financing Activities 21.53M 6.745M 30.33M
Net Change In Cash 43.19M 20.94M 77.39M
YoY Change 308.94% -72.86% 0.66%
FREE CASH FLOW
Cash From Operating Activities $24.45M $27.08M $67.23M
Capital Expenditures $1.888M $1.910M $2.457M
Free Cash Flow $22.56M $25.17M $64.77M
YoY Change 115.43% 184.49% 156.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001565687
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2024 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-08-31
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
001-40550
CY2024 dei Entity Registrant Name
EntityRegistrantName
Intapp, Inc.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1467620
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
3101 Park Blvd
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94306
CY2024 dei City Area Code
CityAreaCode
650
CY2024 dei Local Phone Number
LocalPhoneNumber
852-0400
CY2024 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024 dei Trading Symbol
TradingSymbol
INTA
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
false
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
1300000000
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74699528
CY2024 dei Auditor Firm
AuditorFirmId
34
CY2024 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2024 dei Auditor Location
AuditorLocation
San Jose, California
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208370000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130377000
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
808000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1406000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
994000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95103000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92973000
CY2024Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
13300000
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
10661000
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2743000
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
878000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9031000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7335000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
13907000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
11807000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
342654000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
254839000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18944000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16366000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21382000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17180000
CY2024Q2 us-gaap Goodwill
Goodwill
285969000
CY2023Q2 us-gaap Goodwill
Goodwill
278890000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40293000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43257000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
18495000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
16529000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5262000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1846000
CY2024Q2 us-gaap Assets
Assets
732999000
CY2023Q2 us-gaap Assets
Assets
628907000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13348000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6018000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
42066000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39761000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12040000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11626000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
218923000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
191042000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14270000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10902000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
300647000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
259349000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1336000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1422000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3563000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1355000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19605000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16195000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4610000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9378000
CY2024Q2 us-gaap Liabilities
Liabilities
329761000
CY2023Q2 us-gaap Liabilities
Liabilities
287699000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74624000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74624000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68574000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68574000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
75000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
69000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
891681000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
797639000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1336000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1339000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-487182000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-455161000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
403238000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
341208000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
732999000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
628907000
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
430523000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
350873000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
272071000
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
123661000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
111462000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
99083000
CY2024 us-gaap Gross Profit
GrossProfit
306862000
CY2023 us-gaap Gross Profit
GrossProfit
239411000
CY2022 us-gaap Gross Profit
GrossProfit
172988000
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
113634000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
93851000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74412000
CY2024 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
138176000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
132189000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
111905000
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87243000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
81031000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
86127000
CY2024 inta Lease Modification And Impairment
LeaseModificationAndImpairment
0
CY2023 inta Lease Modification And Impairment
LeaseModificationAndImpairment
1601000
CY2022 inta Lease Modification And Impairment
LeaseModificationAndImpairment
0
CY2024 us-gaap Operating Expenses
OperatingExpenses
339053000
CY2023 us-gaap Operating Expenses
OperatingExpenses
308672000
CY2022 us-gaap Operating Expenses
OperatingExpenses
272444000
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-32191000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-69261000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-99456000
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2407000
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2285000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-659000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1250000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29906000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-69920000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-103113000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2115000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-495000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3435000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-32021000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-69425000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-99678000
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.63
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71488000
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71488000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64295000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64295000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61267000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61267000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-32021000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-69425000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-99678000
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
333000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1178000
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
333000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1178000
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32018000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-69092000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100856000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-157580000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10211000
CY2022 inta Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
2214000
CY2022 inta Share Based Compensation Arrangement By Share Based Payment Award Vesting Of Performance Stock And Restricted Stock Awards Value Net Of Shares Withheld For Taxes
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingOfPerformanceStockAndRestrictedStockAwardsValueNetOfSharesWithheldForTaxes
-3923000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1163000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77514000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1178000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-99678000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
255882000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23456000
CY2023 inta Share Based Compensation Arrangement By Share Based Payment Award Vesting Of Performance Stock And Restricted Stock Awards Value Net Of Shares Withheld For Taxes
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingOfPerformanceStockAndRestrictedStockAwardsValueNetOfSharesWithheldForTaxes
-9056000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2700000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67769000
CY2023 inta Stock Issued During Period Value Upon Business Combination
StockIssuedDuringPeriodValueUponBusinessCombination
1035000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
333000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-69425000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
341208000
CY2024 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30726000
CY2024 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3431000
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59895000
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-32021000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
403238000
CY2024 us-gaap Profit Loss
ProfitLoss
-32021000
CY2023 us-gaap Profit Loss
ProfitLoss
-69425000
CY2022 us-gaap Profit Loss
ProfitLoss
-99678000
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16704000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15319000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16742000
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4781000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4639000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3711000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
922000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
541000
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
59895000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
67769000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
77514000
CY2024 inta Lease Modification And Impairment
LeaseModificationAndImpairment
0
CY2023 inta Lease Modification And Impairment
LeaseModificationAndImpairment
1601000
CY2022 inta Lease Modification And Impairment
LeaseModificationAndImpairment
0
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2407000
CY2024 inta Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-3290000
CY2023 inta Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-1762000
CY2022 inta Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-2776000
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-22000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-912000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4237000
CY2024 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-239000
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-154000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
133000
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5138000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26402000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18205000
CY2024 inta Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
2639000
CY2023 inta Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
3898000
CY2022 inta Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
-1347000
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5740000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1261000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-905000
CY2024 inta Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-4066000
CY2023 inta Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-3394000
CY2022 inta Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-7977000
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9438000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2313000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15589000
CY2024 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
28261000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
46565000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
35345000
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4266000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5922000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
CY2024 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1384000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1341000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3148000
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
67231000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27487000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14236000
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2457000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2212000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
554000
CY2024 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6398000
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
5524000
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4233000
CY2024 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10973000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6604000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2500000
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19828000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14340000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7287000
CY2024 us-gaap Repayments Of Debt
RepaymentsOfDebt
0
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
0
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
278000000
CY2024 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
70080000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
292758000
CY2024 inta Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
781000
CY2023 inta Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
790000
CY2022 inta Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
4358000
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30726000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23456000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10211000
CY2024 inta Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
3431000
CY2023 inta Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
2700000
CY2022 inta Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
1163000
CY2024 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9056000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3923000
CY2024 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
769000
CY2024 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3051000
CY2023 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
22290000
CY2022 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
10435000
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30325000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64100000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6647000
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-343000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-373000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-748000
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
77385000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
76874000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12848000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
131185000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54311000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41463000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
208570000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
131185000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54311000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208370000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130377000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50783000
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
200000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
808000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3528000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
208570000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131185000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54311000
CY2024 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
3000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5950000
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2184000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1812000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
864000
CY2024 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
69000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
517000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
28000
CY2024 inta Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities
CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities
-702000
CY2023 inta Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities
CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities
-378000
CY2022 inta Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities
CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities
0
CY2024 inta Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
0
CY2023 inta Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
776000
CY2022 inta Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
0
CY2024 inta Convertible Preferred Stock Converted To Common Stock Upon Initial Public Offering
ConvertiblePreferredStockConvertedToCommonStockUponInitialPublicOffering
0
CY2023 inta Convertible Preferred Stock Converted To Common Stock Upon Initial Public Offering
ConvertiblePreferredStockConvertedToCommonStockUponInitialPublicOffering
0
CY2022 inta Convertible Preferred Stock Converted To Common Stock Upon Initial Public Offering
ConvertiblePreferredStockConvertedToCommonStockUponInitialPublicOffering
144148000
CY2024 inta Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
0
CY2023 inta Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
0
CY2022 inta Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
2214000
CY2024 inta Deferred Consideration Included In Accounts Payable Accrued Liabilities And Other Liabilities
DeferredConsiderationIncludedInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
1262000
CY2023 inta Deferred Consideration Included In Accounts Payable Accrued Liabilities And Other Liabilities
DeferredConsiderationIncludedInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
0
CY2022 inta Deferred Consideration Included In Accounts Payable Accrued Liabilities And Other Liabilities
DeferredConsiderationIncludedInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
10390000
CY2024 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0
CY2023 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
1035000
CY2022 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0
CY2024 inta Acquisition Holdbacks In Other Liabilities
AcquisitionHoldbacksInOtherLiabilities
1691000
CY2023 inta Acquisition Holdbacks In Other Liabilities
AcquisitionHoldbacksInOtherLiabilities
1624000
CY2022 inta Acquisition Holdbacks In Other Liabilities
AcquisitionHoldbacksInOtherLiabilities
1500000
CY2024 inta Fair Value Of Contingent Considerations In Accrued And Other Liabilities
FairValueOfContingentConsiderationsInAccruedAndOtherLiabilities
99000
CY2023 inta Fair Value Of Contingent Considerations In Accrued And Other Liabilities
FairValueOfContingentConsiderationsInAccruedAndOtherLiabilities
4317000
CY2022 inta Fair Value Of Contingent Considerations In Accrued And Other Liabilities
FairValueOfContingentConsiderationsInAccruedAndOtherLiabilities
4126000
CY2024 inta Non Cash Or Part Noncash Acquisition Cash Paid
NonCashOrPartNoncashAcquisitionCashPaid
13967000
CY2023 inta Non Cash Or Part Noncash Acquisition Cash Paid
NonCashOrPartNoncashAcquisitionCashPaid
6711000
CY2022 inta Non Cash Or Part Noncash Acquisition Cash Paid
NonCashOrPartNoncashAcquisitionCashPaid
2500000
CY2024 inta Non Cash Or Part Noncash Acquisition Cash Acquired
NonCashOrPartNoncashAcquisitionCashAcquired
2994000
CY2023 inta Non Cash Or Part Noncash Acquisition Cash Acquired
NonCashOrPartNoncashAcquisitionCashAcquired
107000
CY2022 inta Non Cash Or Part Noncash Acquisition Cash Acquired
NonCashOrPartNoncashAcquisitionCashAcquired
0
CY2024 inta Non Cash Or Part Noncash Acquisition Consideration
NonCashOrPartNoncashAcquisitionConsideration
10973000
CY2023 inta Non Cash Or Part Noncash Acquisition Consideration
NonCashOrPartNoncashAcquisitionConsideration
6604000
CY2022 inta Non Cash Or Part Noncash Acquisition Consideration
NonCashOrPartNoncashAcquisitionConsideration
2500000
CY2024 us-gaap Nature Of Operations
NatureOfOperations
<p id="note_1_description_of_business" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1. Description of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Intapp, Inc. (“Intapp” or the “Company”), formerly known as LegalApp Holdings, Inc., was incorporated in Delaware in November 2012. The Company is a holding company and conducts its operations through its wholly-owned subsidiary, Integration Appliance, Inc.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Intapp is a leading global provider of AI-powered solutions for professionals at advisory, capital markets and legal firms. The Company empowers the world’s premier accounting, consulting, investment banking, legal, private capital and real assets firms with the technology they need to operate more competitively, deliver timely insights to their professionals, and meet rapidly changing client, investor, and regulatory requirements. Using the power of Applied AI, its purpose-built vertical software as a service (“SaaS”) solutions accelerate the flow of information firmwide, activate expertise, empower teams, strengthen client relationships, manage risk, and help firms adapt more quickly in a highly complex ecosystem. The Company serves clients primarily in the United States (“U.S.”) and the United Kingdom (“U.K.”). References to “the Company,” “us,” “we,” or “our” in these consolidated financial statements refer to the consolidated operations of Intapp and its consolidated subsidiaries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Those estimates and assumptions include, but are not limited to, revenue recognition including determination of the standalone selling price (“SSP”) of the deliverables included in multiple deliverable revenue arrangements; allowance for credit losses; the depreciable lives of long-lived assets including intangible assets; the expected useful life of deferred commissions; the fair value of stock-based awards; the fair value of assets acquired and liabilities assumed in business combinations; goodwill and long-lived assets impairment assessment; the fair value of contingent consideration liabilities; the incremental borrowing rate used to determine the operating lease liabilities; valuation allowances on deferred tax assets; uncertain tax positions; and loss contingencies. The Company evaluates estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, and those differences could be material to the consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024 us-gaap Advertising Expense
AdvertisingExpense
1500000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
1300000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1300000
CY2024 inta Stock Based Compensation Recognized On Straight Line Basis Over Period
StockBasedCompensationRecognizedOnStraightLineBasisOverPeriod
P4Y
CY2024 inta Share Based Compensation Arrangement By Share Based Payment Award Unvested Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedCompensationCost
0
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2024 inta Capitalized Internal Use Software Estimated Useful Life
CapitalizedInternalUseSoftwareEstimatedUsefulLife
P4Y
CY2024 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2024Q2 us-gaap Acquired Finite Lived Intangible Asset Residual Value
AcquiredFiniteLivedIntangibleAssetResidualValue
0
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk and Significant Clients</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. The Company maintains its cash and cash equivalents with multiple high credit quality financial institutions. The Company is exposed to credit risk for cash held in financial institutions to the extent that such amounts recorded on the balance sheet are in excess of amounts that are insured by the Federal Deposit Insurance Corporation. The Company has not experienced any such losses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> client individually accounted for 10% or more of the Company’s revenues for any of the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024, 2023 and 2022. As of June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> client individually accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the Company’s total accounts receivable, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
430523000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
350873000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
272071000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
28336000
CY2022Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
24942000
CY2024 inta Capitalized Contract Cost Amount Capitalized
CapitalizedContractCostAmountCapitalized
18856000
CY2023 inta Capitalized Contract Cost Amount Capitalized
CapitalizedContractCostAmountCapitalized
16242000
CY2024 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-14790000
CY2023 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-12848000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
32402000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
28336000
CY2024Q2 inta Unbilled Receivables Current And Noncurrent
UnbilledReceivablesCurrentAndNoncurrent
13363000
CY2023Q2 inta Unbilled Receivables Current And Noncurrent
UnbilledReceivablesCurrentAndNoncurrent
10765000
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
222486000
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
192397000
CY2024Q2 inta Unbilled Receivables Noncurrent
UnbilledReceivablesNoncurrent
63000
CY2023Q2 inta Unbilled Receivables Noncurrent
UnbilledReceivablesNoncurrent
104000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2024 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
190400000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
566500000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.55
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Goodwill
Goodwill
278890000
CY2022Q2 us-gaap Goodwill
Goodwill
269103000
CY2024 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
7072000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
8669000
CY2024 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0
CY2023 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
784000
CY2024 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
7000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
334000
CY2024Q2 us-gaap Goodwill
Goodwill
285969000
CY2023Q2 us-gaap Goodwill
Goodwill
278890000
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
127896000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87603000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40293000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
119831000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
76574000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43257000
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11029000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10773000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13519000
CY2024 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
11163000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7835000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5121000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4623000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3252000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
3616000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35610000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35559000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27984000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16615000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11618000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18944000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16366000
CY2024 us-gaap Depreciation
Depreciation
2100000
CY2023 us-gaap Depreciation
Depreciation
1600000
CY2022 us-gaap Depreciation
Depreciation
1300000
CY2024 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
6800000
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
5900000
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
4200000
CY2024 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
3600000
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2900000
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1900000
CY2024Q2 inta Net Book Value Of Capitalized Software Development Costs
NetBookValueOfCapitalizedSoftwareDevelopmentCosts
13500000
CY2023Q2 inta Net Book Value Of Capitalized Software Development Costs
NetBookValueOfCapitalizedSoftwareDevelopmentCosts
10300000
CY2024 inta Lessee Operating Lease Expiration Year
LesseeOperatingLeaseExpirationYear
2030
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1600000
CY2024 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
additional 12 months through August 2025
CY2024 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2024 inta Adjustment Of Right Of Use Asset And Lease Liability
AdjustmentOfRightOfUseAssetAndLeaseLiability
2200000
CY2023 inta Adjustment Of Right Of Use Asset And Lease Liability
AdjustmentOfRightOfUseAssetAndLeaseLiability
2500000
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
6353000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
6113000
CY2024 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1290000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
843000
CY2024 us-gaap Variable Lease Cost
VariableLeaseCost
455000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
0
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1600000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
9000000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
5847000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
7582000
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8983000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3253000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6000000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4700000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7558000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5273000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4324000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4617000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5032000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3760000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
30564000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4956000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
25608000
CY2024Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
5459000
CY2024Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
3106000
CY2024Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
2816000
CY2024Q2 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
2879000
CY2024Q2 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
800000
CY2024Q2 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
1600000
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
16660000
CY2024 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
all outstanding shares of Series A and Series A-1 convertible preferred stock were automatically converted into 19,034,437 shares of the Company’s common stock on a one-for-one basis.
CY2021Q3 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
19034437
CY2021Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
20220000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12773000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.56
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
65284000
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2313000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.14
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
323000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
18.08
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10137000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.42
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
319250000
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3105000
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.9
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
166000
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
20.7
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6866000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.4
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
180360000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6632000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.04
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M18D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
176657000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6866000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.4
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
180360000
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59895000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
67769000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
77514000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
106900000
CY2024 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-34220000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-72871000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-104391000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
4314000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2951000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1278000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29906000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-69920000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-103113000
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-246000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-48000
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1307000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
226000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
278000
CY2024 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
830000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
437000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
572000
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2137000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
417000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
802000
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-154000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
137000
CY2024 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
34000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-327000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
131000
CY2024 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-56000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-431000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-4505000
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-22000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-912000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4237000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2115000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-495000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3435000
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6280000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14683000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21654000
CY2024 inta Income Tax Reconciliation State Tax Net Of Federal Benefit
IncomeTaxReconciliationStateTaxNetOfFederalBenefit
935000
CY2023 inta Income Tax Reconciliation State Tax Net Of Federal Benefit
IncomeTaxReconciliationStateTaxNetOfFederalBenefit
192000
CY2022 inta Income Tax Reconciliation State Tax Net Of Federal Benefit
IncomeTaxReconciliationStateTaxNetOfFederalBenefit
140000
CY2024 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2943000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1888000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
-1019000
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-9364000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-3311000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
6828000
CY2024 inta Income Tax Reconciliation Acquisition Related Transaction Costs
IncomeTaxReconciliationAcquisitionRelatedTransactionCosts
162000
CY2023 inta Income Tax Reconciliation Acquisition Related Transaction Costs
IncomeTaxReconciliationAcquisitionRelatedTransactionCosts
254000
CY2022 inta Income Tax Reconciliation Acquisition Related Transaction Costs
IncomeTaxReconciliationAcquisitionRelatedTransactionCosts
53000
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
19448000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
20764000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10802000
CY2024 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
157000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-1823000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-623000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2115000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-495000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3435000
CY2024Q2 inta Deferred Tax Assets Nondeductible Accrued Expenses
DeferredTaxAssetsNondeductibleAccruedExpenses
3243000
CY2023Q2 inta Deferred Tax Assets Nondeductible Accrued Expenses
DeferredTaxAssetsNondeductibleAccruedExpenses
2658000
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31153000
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29054000
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9551000
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6634000
CY2024Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
47930000
CY2023Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
22934000
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7437000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11079000
CY2024Q2 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
13765000
CY2023Q2 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
14342000
CY2024Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
588000
CY2023Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
709000
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
67000
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
234000
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
100543000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
71911000
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13191000
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15733000
CY2024Q2 inta Deferred Tax Liabilities Deferred Commissions
DeferredTaxLiabilitiesDeferredCommissions
6614000
CY2023Q2 inta Deferred Tax Liabilities Deferred Commissions
DeferredTaxLiabilitiesDeferredCommissions
5906000
CY2024Q2 inta Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
3089000
CY2023Q2 inta Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
2479000
CY2024Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4196000
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
8090000
CY2024Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13899000
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
16475000
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
708000
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
742000
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
100500000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
71900000
CY2024Q2 inta Accumulated Undistributed Earnings Generated By Foreign Subsidiaries
AccumulatedUndistributedEarningsGeneratedByForeignSubsidiaries
26200000
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5311000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3811000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2970000
CY2024 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
173000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
532000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
396000
CY2024 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1392000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
968000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
445000
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6876000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5311000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3811000
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6900000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5300000
CY2024Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-32021000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-69425000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-99678000
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71488000
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71488000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64295000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64295000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61267000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61267000
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.63
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.63
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12015000
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15955000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17262000
CY2012Q4 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
1
CY2012Q4 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
1
CY2024 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
4300000
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
3800000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
3000000.0
CY2024 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2400000
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1300000

Files In Submission

Name View Source Status
0000950170-24-100587-index-headers.html Edgar Link pending
0000950170-24-100587-index.html Edgar Link pending
0000950170-24-100587.txt Edgar Link pending
0000950170-24-100587-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img117092606_0.jpg Edgar Link pending
img158320780_0.jpg Edgar Link pending
inta-20240630.htm Edgar Link pending
inta-20240630.xsd Edgar Link pending
inta-ex10_29.htm Edgar Link pending
inta-ex10_30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
inta-20240630_htm.xml Edgar Link completed
inta-ex21_1.htm Edgar Link pending
inta-ex23_1.htm Edgar Link pending
inta-ex31_1.htm Edgar Link pending
inta-ex31_2.htm Edgar Link pending
inta-ex32_1.htm Edgar Link pending
inta-ex32_2.htm Edgar Link pending
inta-ex97_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending